Sellas Life Sciences Group Inc Corporate Analyst Meeting Transcript
Well, good morning, everyone. I'm Angelos Stergiou, President and CEO of SELLAS. And a very warm welcome to our first R&D event. It's really an honor to be here today, and I'm very happy to see so many familiar faces, actually. And -- in the audience, and for those of us joining us via webcast, thanks for joining in. Firstly, I would like to thank our shareholders for their continued support. The Board and management are committed to the goal to create value for our shareholders and to develop life-saving drugs. We're very pleased to host because we had to share some exciting information and data around SELLAS' lead assets and program around galinpepimut-S or GPS in short. And so I'm just going to cut right to it. But first, we're going to be making forward-looking statements today, so please refer to the filing on our website to remind yourself of the risk factors.
Today, we hope to convey a theme really of growth and transformation since SELLAS started trading on NASDAQ last year, and we're
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |